Vestal Point Capital »

Reneo Pharmaceuticals shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 799k 1.70
2024-06-30 $823k 545k 1.51

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding Reneo Pharmaceuticals

NEA Management Company
BML Capital Management
Highbridge Capital Management
Tang Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
Ikarian Capital
Aisling Capital Management
Vanguard Group
Vestal Point Capital
Nantahala Capital Management
Renaissance Technologies
Aldebaran Capital
Acuitas Investments

View all funds holding Reneo Pharmaceuticals